LASIK: some still in the dark

Article

I recently attended a party where I was drawn into a conversation by some people who had one thing in common – LASIK. Somebody amongst the group had undergone the procedure six years ago (incidentally, that was my sister) whilst another underwent wavefront-guided LASIK just weeks prior. Each of the four people had a story to tell about their experience with the procedure but, overall, each claimed they were happy with the end result.

During the conversation, however, my sister made a comment that roused a passionate response. "I was told that I would have LASIK in the morning and by the afternoon, I could go shopping if I liked. They lied. I was in agony for the first day and for days thereafter the pain had lessened but it was still constant. I was beside myself and thought it had all gone wrong," she said.

The conversation that followed was very different. Each person had faced similar experiences in that they were not prepared for the pain and/or complications that ensued. As a result, they felt that perhaps the procedure simply "hadn't worked properly for them."

This made me question how laser refractive surgery was being perceived by the public. With certain laser refractive centres constantly inundating consumers with advertising campaigns touting the benefits of laser eye surgery; the fact that it's quick, simple, painless, effective and "If you book now, you could get two eyes done for the price of one," perhaps the majority of people now believe laser eye surgery to be completely risk- and complication-free.

I certainly believe that media campaigns have contributed a great deal to the explosion witnessed by the laser refractive surgery industry in recent years. Question marks still remain, however, over whether after-care and complications management is discussed in sufficient detail in certain clinics.

I would welcome your thoughts on this matter. Do you think it's easy to communicate these messages to your patients or are patients merely interested in hearing about the improvements in their vision? Is there enough time in the working day to discuss everything with the patient, particularly with the advent of new and expensive technologies placing a huge burden on surgeries to perform high volumes of procedures?

I would love to hear what you have to say.

On another note, you may have noticed the competition that we are currently running, offering you the opportunity to win a trip for two to Berlin, in time for this year's ESCRS congress in September. You can enter by simply completing the subscription renewal form within this issue of OTE or by going to http://www.oteurope.com/ and following the instructions from the homepage. The winner will be announced in June.

Good luck!

Fedra PavlouEditorfpavlou@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.